Spain· ES:1191359001
TROGARZO 200 mg CONCENTRADO PARA SOLUCION PARA PERFUSION
A ibalizumab product containing ibalizumab, registered in Spain by Theratechnologies Europe Limited. The same ATC class is registered in 4 of our 19 countries.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
Where it is registered
Ibalizumab is registered in 4 of 19 countries.
Countries holding a registration under ATC J05AX23 (ibalizumab), each read from that country’s own register.
- This record: Spain, from AEMPS CIMA (Spain)
- 4 of them publish a price we can compare per daily dose
Ibalizumab · ATC J05AX23
4 / 19 countries
- Belgiumprice
- Finlandprice
- Spainprice
- United Statesprice
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- ibalizumab
- Manufacturer
- Theratechnologies Europe Limited
- Country
- Spain (ES)
- ATC code
- J05AX23
- ATC class
- Ibalizumab
- Defined daily dose
- 57 mg, P
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 3, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ibalizumab in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/42fa2d7e-87f1-4cd2-a1ef-f27c659fbd56 GET /v1/drugs/42fa2d7e-87f1-4cd2-a1ef-f27c659fbd56?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1615885528000,\"rev\":1673423847000}",
"nregistro": "1191359001",
"substance": "ibalizumab"
}See everything about ibalizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.